A phase 1b study of andecaliximab in combination with S-1 plus platinum in Japanese patients with gastric adenocarcinoma by Ooki, Akira, Satoh, Taroh, Muro, Kei, Takashima, Atsuo, Kadowaki, Shigenori, Sakai, Daisuke, Ichimura, Takashi, Mitani, Seiichiro, Kudo, Toshihiro, Chin, Keisho, Kitano, Shigehisa, Thai, Dung, Zavodovskaya, Marianna, Liu, JieJane, Boku, Narikazu, Yamaguchi, Kensei

Get full text

Safety and tolerability of andecaliximab as monotherapy and in combination with an anti-PD-1 antibody in Japanese patients with gastric or gastroesophageal junction adenocarcinoma:... by Yoshikawa, Akie Kimura, Yamaguchi, Kensei, Muro, Kei, Takashima, Atsuo, Ichimura, Takashi, Sakai, Daisuke, Kadowaki, Shigenori, Chin, Keisho, Kudo, Toshihiro, Mitani, Seiichiro, Kitano, Shigehisa, Thai, Dung, Zavodovskaya, Marianna, Liu, JieJane, Boku, Narikazu, Satoh, Taroh

Get full text

Safety and Efficacy of Andecaliximab (GS‐5745) Plus Gemcitabine and Nab‐Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study by Bendell, Johanna, Sharma, Sunil, Patel, Manish R., Windsor, Kevin S., Wainberg, Zev A., Gordon, Michael, Chaves, Jorge, Berlin, Jordan, Brachmann, Carrie Baker, Zavodovskaya, Marianna, Liu, JieJane, Thai, Dung, Bhargava, Pankaj, Shah, Manish A., Khan, Saad A., Starodub, Alexander

Get full text